Table 1.

Activation of both Syk and Lyn tyrosine kinases by treatment of intact erythrocytes

Treatment
Tyrosine kinase activity, cpm
Anti-Syk IPAnti-Lyn IP
None 2 730 1 010 
Pervanadate 5 948 10 566  
Pervanadate + PP2 5 725 910  
Diamide 6 215 10 416  
Diamide + PP2 5 838 1 120  
NEM 6 063 10 275  
NEM + PP2 5 790 930 
Treatment
Tyrosine kinase activity, cpm
Anti-Syk IPAnti-Lyn IP
None 2 730 1 010 
Pervanadate 5 948 10 566  
Pervanadate + PP2 5 725 910  
Diamide 6 215 10 416  
Diamide + PP2 5 838 1 120  
NEM 6 063 10 275  
NEM + PP2 5 790 930 

Human erythrocytes were incubated without or with 1 mmol/L pervanadate, 2 mmol/L diamide, and 1 mmol/L NEM in the absence or presence of 5 μM PP2. Isolated erythrocyte membranes were treated with extraction buffer, and extracted proteins were immunoprecipitated with anti-Syk or anti-Lyn antibodies. Tyrosine kinase activities of immunocomplexes were tested in vitro, as described in “Materials and methods.” Reported values represent the means for 4 separate experiments. SEMs were always less than 20%. IP indicates immunoprecipitate; NEM, N-ethylmaleimide.

Close Modal

or Create an Account

Close Modal
Close Modal